VYNE vs AAPL: Which Stock is Better?
Side-by-side comparison of Vyne Therapeutics Inc and Apple Inc in 2026
VYNE
Vyne Therapeutics Inc
$28.56
AAPL
Apple Inc
$325.13
Key Metrics Comparison
| Metric | VYNE | AAPL | Winner |
|---|---|---|---|
| Market Cap | $21.07M | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | VYNE |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 18.2% | 7.9% | VYNE |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze VYNE
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is VYNE or AAPL a better investment?
Comparing VYNE and AAPL: Vyne Therapeutics Inc has a market cap of $21.07M while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between VYNE and AAPL?
VYNE (Vyne Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: VYNE or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: VYNE or AAPL?
VYNE has higher revenue growth at 18.2% vs 7.9% for AAPL.
Which company is more profitable: VYNE or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for VYNE.
Which is the larger company: VYNE or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $21.07M for VYNE.
Should I buy VYNE or AAPL in 2026?
Both VYNE and AAPL have investment merit. VYNE trades at $28.56 while AAPL trades at $325.13. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between VYNE and AAPL stock?
Key differences: Market Cap ($21.07M vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (18.2% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy VYNE or AAPL in 2026?
The choice between VYNE and AAPL depends on your investment goals. VYNE shows higher revenue growth (18.2%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between VYNE and AAPL?
VYNE (Vyne Therapeutics Inc) has a market cap of $21.07M, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.